Table 3 Clinical characteristics of recovered COVID-19 patients
From: Longitudinal alterations of the gut mycobiota and microbiota on COVID-19 severity
Patient ID | Age | Gender | Duration from 1st to 2nd sampling (days) | Comorbidities |
|---|---|---|---|---|
Cov3 | 58 | Male | 241 | Hypertension, hyperuricemia, fatty liver |
Cov4 | 68 | Male | 244 | None |
Cov10 | 74 | Male | 222 | Hypertension, dyslipidemia, hyperuricemia |
Cov14 | 73 | Male | 71 | Hypertension, DM |
Cov18 | 64 | Male | 153 | Dilated cardiomyopathy |
Cov22 | 76 | Male | 144 | RA (no treatment), DM |
Cov25 | 56 | Male | 180 | Hypertension, dyslipidemia |
Cov27 | 72 | Female | 155 | Dyslipidemia |
Cov28 | 63 | Female | 155 | DM, dyslipidemia, hashimoto-disease |
Cov39 | 50 | Male | 120 | None |